《Drugs In R&d》是一本由SPRINGER INTERNATIONAL PUBLISHING AG出版商出版的专业医学期刊，该刊创刊于1999年，刊期4 issues a year, 2010-，该刊已被国际权威数据库SCIE收录。在中科院最新升级版分区表中，该刊分区信息为大类学科：医学 4区，小类学科：药学 4区；在JCR（Journal Citation Reports）分区等级为Q3。该刊发文范围涵盖药学等领域，旨在及时、准确、全面地报道国内外药学工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等，促进学术交流，鼓励学术创新。2021年影响因子为3.203，平均审稿速度8 Weeks。

Drugs In R&d英文介绍

Drugs in R&D is an international, peer reviewed, open access, online only journal, and provides timely information from all phases of drug research and development that will inform clinical practice. Healthcare decision makers are thus provided with knowledge about the developing place of a drug in therapy.

The Journal includes:

Clinical research on new and established drugs;

Preclinical research of direct relevance to clinical drug development;

Short communications and case study reports that meet the above criteria will also be considered;

Reviews may also be considered.

Drugs In R&d中科院分区

大类学科	分区	小类学科	分区	Top期刊	综述期刊
医学	4区	PHARMACOLOGY & PHARMACY 药学	4区	否	否

Drugs In R&d期刊近9年JCR分区变化趋势

Drugs In R&dJCR分区(JCR2021-2022年分区)

JCR分区等级	JCR所属学科	分区	影响因子
Q3	PHARMACOLOGY & PHARMACY	Q3	3.203

Drugs In R&d期刊近7年影响因子变化趋势

Drugs In R&d期刊的CiteScore值(CiteScore2021-2022年CiteScore值)

CiteScore	SJR	SNIP	学科类别	分区	排名	百分位
4.30	0.665	0.952	大类：Pharmacology, Toxicology and Pharmaceutics 小类：Pharmacology	Q2	150 / 303	50%

Drugs In R&d期刊近7年自引率变化趋势

上周TOP10